Rhema takes over Harmony Concepts
The funding from First West Capital supported the acquisition of US custom manufacturing company for nutritional and dietary supplements and herbal blends. The Rhema Group president and chief
The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.
The collaboration aims to provide the clinical laboratory market with an integrated workflow to support next generation sequencing-based tests. Ingenuity will provide content and software for the analysis
AmerisourceBergen’s new expanded partnership with Walgreens and Alliance Boots comprises a ten-year comprehensive primary pharmaceutical distribution contract with Walgreens; access to generic drugs and related pharmaceutical products through